{"id":212100,"name":"ROMARK","slug":"romark","state":"FL","country":"United States of America","description":"Pharmaceutical company","totalSpending":140000,"filings":8,"yearlySpending":[{"year":2021,"income":60000},{"year":2022,"income":80000},{"year":2023,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"DIS","display":"Disaster Planning/Emergencies"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["PRIME POLICY GROUP"],"lobbyists":["RICH MEADE","PAUL WEISS","MITCHELL VAKERICS","CALLIE BARNARD","PAMELA TURNER"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)","White House Office"],"sampleDescriptions":["Raising profile of therapy and impact on pandemic mitigation.","Clinical trials for therapies","ARPA, emergency use authorization for COVID-19 therapeutic","ARPA, emergency use authorization for COVID-19 therapeutic","ARPA, emergency use authorization for COVID-19 therapeutic"]}